SEC Initiates Formal Investigation Into Vioxx Withdrawal
This article was originally published in The Pink Sheet Daily
Executive Summary
Escalation of SEC's "informal inquiry" is "not unexpected," Merck says. Company anticipates a federal judicial panel will rule in several weeks on motions to consolidate Vioxx personal injury and shareholder lawsuits for coordinated pretrial proceedings.